Regeneron
Clonal Hematopoiesis Linked to Common, Rare Genetic Variants
Analyzing almost 628,400 exome sequences, researchers found common and rare variants corresponding with different forms of clonal hematopoiesis of indeterminate potential.
Recently compiled Mexican population genetic datasets reveal historical population structures, predict complex traits, and improve bioinformatic tools.
While Regeneron has more than 100 other sequencing collaborations, including with All of Us and UK Biobank, none approaches the scale of its new plans with Mount Sinai Health System.
Mount Sinai, Regeneron Launch Sequencing Project to Augment Genetics-Based Precision Medicine
The program, named Mount Sinai Million Health Discoveries Program, aims to enroll 1 million Mount Sinai patients over a five-year period for sequencing.
Exome Sequencing Study Uncovers Rare Variants in Gene Protecting Against Liver Disease
The findings of the study, which was funded by Regeneron Pharmaceuticals, suggest a new treatment for conditions like nonalcoholic steatohepatitis (NASH).